The TSC1 gene product, hamartin, negatively regulates cell proliferation

Human Molecular Genetics

Volumn 9, Issue 12, 2000, Pages 1721-1727

  Miloloza, Angelina ^a   Rosner, Margit ^a   Nellist, Mark ^b   Halley, Dicky ^b   Bernaschek, Gerhard ^a   Hengstschläger, Markus ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HAMARTIN; TUBERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHROMOSOME 16P; CHROMOSOME 9Q; CONTROLLED STUDY; GENE MUTATION; IMMUNOBLOTTING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0033861013     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.12.1721     Document Type: Article

References (28)

1. The genetic basis of tuberous sclerosis
2. Epidemiology of tuberous sclerosis
3. The tuberous sclerosis collaborative group linkage investigation of three putative tuberous sclerosis determining loci on chromosome 9q, 11q and 12q
4. Report on the second international workshop on human chromosome 9
5. The European chromosome 16 tuberous sclerosis consortium identification and characterization of the tuberous sclerosis gene on chromosome 16
6. Two loci for tuberous sclerosis: One on 9q34 and one on 16p13
7. Redefined localization of TSC1 by combined analysis of 9q34 and 16p34 data on 14 tuberous sclerosis families
8. The molecular genetics of tuberous sclerosis
9. The TSC1 consortium identification of the tuberous sclerosis gene TSC1 on chromosome 9q34
10. Identification of tuberin, the tuberous sclerosis-2 product
11. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model
12. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis
13. Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members
14. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (TSC2) gene and its C-terminal region
15. Suppression of the neoplastic phenotype by replacement of the TSC2 gene in Eker rat renal carcinoma cells. Biochem
16. Role of the tuberous sclerosis gene-2 product in cell cycle control
17. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2
18. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products
19. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles
20. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
21. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins
22. The retinoblastoma protein and cell cycle control
23. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation
24. Human cancer syndromes: Clues to the origin and nature of cancer
25. Gigas, a drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle
26. Association of human cyclin E with a periodic G1-S phase protein kinase
27. Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry